Claim it free in under 5 minutes — verified by GSTIN, DigiLocker, or WhatsApp OTP. You control what buyers see, respond to inquiries, and post on RFQs.
Avammune is an R&D-driven drug discovery company developing novel modality-agnostic best-in-class and first-in-class therapies for hard-to-treat solid tumors. Our team brings deep expertise across medicinal chemistry, immunology, discovery biology, and computational chemistry, with a track record of scientific innovation, IP creation, and successful exits. We collaborate to co-develop oncology assets, accelerate preclinical programs, and expand access to next-generation cancer therapeutics.
Arun is a serial biotech entrepreneur and previously co-founded Aten Porus Lifesciences and Oraxion Therapeutics, both drug discovery compan…
Aditya previously co-founded Aten Porus Lifesciences and Oraxion Therapeutics. He is also the inventor of Oraxion’s technology platform that…
Srinivasan previously co-founded Aten Porus Lifesciences and Oraxion Therapeutics, and was instrumental in Aten’s exit to Bain Private Equit…
Sandeep is a medicinal chemist with over a decade of experience in NCE design, synthesis, and structure-/ligand-based drug discovery. He has…
Avijit is a biochemist and immunologist by training with over 8 years of experience in RNA biology, host-pathogen interactions, and immune m…
Princy has over 11 years of experience in preclinical R&D and drug discovery program management. Her expertise spans data-driven decision-ma…
Sunny has over 14 years of experience in accounts, finance, and administrative operations. As Senior Manager – Accounts & Administration, hi…
Anchored to live government registries — MCA, GSTN, DGFT, EPFO. No pay-to-play badges. Refreshed weekly.
Limited government data available — 5 criteria met
AVAMMUNE LIFESCIENCES PRIVATE LIMITED is anchored to the official records above. Anything self-declared by the company is labelled separately on this page. Check another company free →
Other verified manufacturers in the same network — discovered via MCA21 cross-references.